Record Q2 2026 revenue of approximately $19.4 million, up approximately 31.5% year-over-year from $14.75 million in Q2 2025Record first-half 2026 revenue of approximately $37.3 million, up approximately 31% from $28.46 million in H1 20253,640,000 sha

Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 trial Rolling submission of NDA for daraxonrasib to U.S.

FAIR LAWN, N.J., July 07, 2026 (GLOBE NEWSWIRE) -- Columbia Financial, Inc. (NASDAQ: CLBK), a Delaware corporation and the mid-tier holding company for Columbia Bank (the “Holding Company” or “Columbia”), announced today that Columbia Financial, Inc.

Guelph, Ontario--(Newsfile Corp. - July 7, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce that Quality Filters Inc. ("Quality"), its U.S.-based manufacturing and distribution partner headquartered in

Recall campaigns tied to AI infrastructure are an emerging trendMiddleton, Wisconsin--(Newsfile Corp. - July 7, 2026) - Ballotpedia has identified 33 recall efforts related to data center development during the first six months of 2026, an early indi

Initial Deployment Brings Omni One Systems to Sirica's First Bay Area Treatment Center Collaboration Builds on Rutgers University Research and Advances Sirica's Plan to Establish 100 Autism Treatment Centers Nationwide AUSTIN, Texas, July 07, 2026 (G

Fort Lauderdale, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME), a leading provider of AI-powered logistics solutions, today provided a summary of the milestones it achieved during the first half of 2026

Transformative transaction intended to maximize stockholder valueRepositions the Company to pursue a new strategic direction in the national security sector Strengthens the Company’s ability to deploy capital toward growth initiatives NEW YORK, July

Vancouver, British Columbia--(Newsfile Corp. - July 7, 2026) - Americore Resources Corp. (TSXV: AMCO) (FSE: 5GP) (OTCQB: AMCOF) (the "Company" or "Americore") is pleased to announce that, further to its press releases dated June 15, 2026, and June 29

eMTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer’s disease Immunoassay for eMTBR-Tau is available in the NULISAseq™ Neuro 220